Table 1.
Correlation of the Expression of miR-939-5p with Clinicopathological Parameters in Patients with PC
| Clinicopathological Parameters | miR-939-5p Expression | P-value | |
|---|---|---|---|
| Low High | |||
| (n=35, 50%) | (n=35, 50%) | ||
| Gender | |||
| Male | 19 (27.1%) | 21 (30.0%) | 0.6291 |
| Female | 16 (22.9%) | 14 (20.0%) | |
| Age (years) | |||
| <60 | 16 (22.9%) | 19 (27.1%) | 0.4733 |
| ≥60 | 19 (27.1%) | 16 (22.9%) | |
| Tumor size (cm) | |||
| ≤4 | 20 (28.6%) | 16 (22.9%) | 0.3388 |
| >4 | 15 (21.4%) | 19 (27.1%) | |
| Pathological stages | 0.0072 | ||
| I | 6 (8.6%) | 4 (5.7%) | |
| II | 20 (28.6%) | 8 (11.4%) | |
| III | 6 (8.6%) | 18 (25.7%) | |
| IV | 3 (4.3%) | 5 (7.1%) | |
| Tumor site | 0.5268 | ||
| Pancreatic head | 14 (20.0%) | 10 (14.3%) | |
| Pancreatic body | 11 (15.7%) | 15 (21.4%) | |
| Pancreatic tail | 10 (14.3%) | 10 (14.3%) | |
Note: Differences between groups were done by the Chi-square test.